The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Medicinal and Food Homologous Health Product Market Research Report 2025

Global Medicinal and Food Homologous Health Product Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1768311

No of Pages : 95

Synopsis
Global Medicinal and Food Homologous Health Product market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medicinal and Food Homologous Health Product market research.
Key manufacturers engaged in the Medicinal and Food Homologous Health Product industry include Isabel Healthcare, Nature's Way, Beijing Tongrentang Co., Ltd., Dong-E-E-Jiao Co., Ltd., By-health Co., Ltd., Zhejiang Renzhichu Health Industry Co., Ltd., Hanguk Insam Gongsa, Shandong Gubentang Health Industry Development Group Co., Ltd. and Renhe Pharmacy Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Medicinal and Food Homologous Health Product were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Medicinal and Food Homologous Health Product market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medicinal and Food Homologous Health Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Isabel Healthcare
Nature's Way
Beijing Tongrentang Co., Ltd.
Dong-E-E-Jiao Co., Ltd.
By-health Co., Ltd.
Zhejiang Renzhichu Health Industry Co., Ltd.
Hanguk Insam Gongsa
Shandong Gubentang Health Industry Development Group Co., Ltd.
Renhe Pharmacy Co., Ltd.
Ningxia Qilixiang Medlar Co., Ltd.
Nu Skin Enterprises
Segment by Type
Oral Beauty
Liver Protection
Sleep Aid
Other Types
Segment by Application
Health Maintenance
Nutritional Supplement
Heart and Brain Health
Joint Health
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medicinal and Food Homologous Health Product report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Medicinal and Food Homologous Health Product Market Overview
1.1 Product Overview and Scope of Medicinal and Food Homologous Health Product
1.2 Medicinal and Food Homologous Health Product Segment by Type
1.2.1 Global Medicinal and Food Homologous Health Product Market Value Comparison by Type (2023-2029)
1.2.2 Oral Beauty
1.2.3 Liver Protection
1.2.4 Sleep Aid
1.2.5 Other Types
1.3 Medicinal and Food Homologous Health Product Segment by Application
1.3.1 Global Medicinal and Food Homologous Health Product Market Value by Application: (2023-2029)
1.3.2 Health Maintenance
1.3.3 Nutritional Supplement
1.3.4 Heart and Brain Health
1.3.5 Joint Health
1.3.6 Others
1.4 Global Medicinal and Food Homologous Health Product Market Size Estimates and Forecasts
1.4.1 Global Medicinal and Food Homologous Health Product Revenue 2018-2029
1.4.2 Global Medicinal and Food Homologous Health Product Sales 2018-2029
1.4.3 Global Medicinal and Food Homologous Health Product Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medicinal and Food Homologous Health Product Market Competition by Manufacturers
2.1 Global Medicinal and Food Homologous Health Product Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medicinal and Food Homologous Health Product Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medicinal and Food Homologous Health Product Average Price by Manufacturers (2018-2023)
2.4 Global Medicinal and Food Homologous Health Product Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medicinal and Food Homologous Health Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicinal and Food Homologous Health Product, Product Type & Application
2.7 Medicinal and Food Homologous Health Product Market Competitive Situation and Trends
2.7.1 Medicinal and Food Homologous Health Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medicinal and Food Homologous Health Product Players Market Share by Revenue
2.7.3 Global Medicinal and Food Homologous Health Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medicinal and Food Homologous Health Product Retrospective Market Scenario by Region
3.1 Global Medicinal and Food Homologous Health Product Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medicinal and Food Homologous Health Product Global Medicinal and Food Homologous Health Product Sales by Region: 2018-2029
3.2.1 Global Medicinal and Food Homologous Health Product Sales by Region: 2018-2023
3.2.2 Global Medicinal and Food Homologous Health Product Sales by Region: 2024-2029
3.3 Global Medicinal and Food Homologous Health Product Global Medicinal and Food Homologous Health Product Revenue by Region: 2018-2029
3.3.1 Global Medicinal and Food Homologous Health Product Revenue by Region: 2018-2023
3.3.2 Global Medicinal and Food Homologous Health Product Revenue by Region: 2024-2029
3.4 North America Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.4.1 North America Medicinal and Food Homologous Health Product Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medicinal and Food Homologous Health Product Sales by Country (2018-2029)
3.4.3 North America Medicinal and Food Homologous Health Product Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.5.1 Europe Medicinal and Food Homologous Health Product Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medicinal and Food Homologous Health Product Sales by Country (2018-2029)
3.5.3 Europe Medicinal and Food Homologous Health Product Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.6.1 Asia Pacific Medicinal and Food Homologous Health Product Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medicinal and Food Homologous Health Product Sales by Country (2018-2029)
3.6.3 Asia Pacific Medicinal and Food Homologous Health Product Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.7.1 Latin America Medicinal and Food Homologous Health Product Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medicinal and Food Homologous Health Product Sales by Country (2018-2029)
3.7.3 Latin America Medicinal and Food Homologous Health Product Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medicinal and Food Homologous Health Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Medicinal and Food Homologous Health Product Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medicinal and Food Homologous Health Product Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medicinal and Food Homologous Health Product Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medicinal and Food Homologous Health Product Sales by Type (2018-2029)
4.1.1 Global Medicinal and Food Homologous Health Product Sales by Type (2018-2023)
4.1.2 Global Medicinal and Food Homologous Health Product Sales by Type (2024-2029)
4.1.3 Global Medicinal and Food Homologous Health Product Sales Market Share by Type (2018-2029)
4.2 Global Medicinal and Food Homologous Health Product Revenue by Type (2018-2029)
4.2.1 Global Medicinal and Food Homologous Health Product Revenue by Type (2018-2023)
4.2.2 Global Medicinal and Food Homologous Health Product Revenue by Type (2024-2029)
4.2.3 Global Medicinal and Food Homologous Health Product Revenue Market Share by Type (2018-2029)
4.3 Global Medicinal and Food Homologous Health Product Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medicinal and Food Homologous Health Product Sales by Application (2018-2029)
5.1.1 Global Medicinal and Food Homologous Health Product Sales by Application (2018-2023)
5.1.2 Global Medicinal and Food Homologous Health Product Sales by Application (2024-2029)
5.1.3 Global Medicinal and Food Homologous Health Product Sales Market Share by Application (2018-2029)
5.2 Global Medicinal and Food Homologous Health Product Revenue by Application (2018-2029)
5.2.1 Global Medicinal and Food Homologous Health Product Revenue by Application (2018-2023)
5.2.2 Global Medicinal and Food Homologous Health Product Revenue by Application (2024-2029)
5.2.3 Global Medicinal and Food Homologous Health Product Revenue Market Share by Application (2018-2029)
5.3 Global Medicinal and Food Homologous Health Product Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Isabel Healthcare
6.1.1 Isabel Healthcare Corporation Information
6.1.2 Isabel Healthcare Description and Business Overview
6.1.3 Isabel Healthcare Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Isabel Healthcare Medicinal and Food Homologous Health Product Product Portfolio
6.1.5 Isabel Healthcare Recent Developments/Updates
6.2 Nature's Way
6.2.1 Nature's Way Corporation Information
6.2.2 Nature's Way Description and Business Overview
6.2.3 Nature's Way Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Nature's Way Medicinal and Food Homologous Health Product Product Portfolio
6.2.5 Nature's Way Recent Developments/Updates
6.3 Beijing Tongrentang Co., Ltd.
6.3.1 Beijing Tongrentang Co., Ltd. Corporation Information
6.3.2 Beijing Tongrentang Co., Ltd. Description and Business Overview
6.3.3 Beijing Tongrentang Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Beijing Tongrentang Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.3.5 Beijing Tongrentang Co., Ltd. Recent Developments/Updates
6.4 Dong-E-E-Jiao Co., Ltd.
6.4.1 Dong-E-E-Jiao Co., Ltd. Corporation Information
6.4.2 Dong-E-E-Jiao Co., Ltd. Description and Business Overview
6.4.3 Dong-E-E-Jiao Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dong-E-E-Jiao Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.4.5 Dong-E-E-Jiao Co., Ltd. Recent Developments/Updates
6.5 By-health Co., Ltd.
6.5.1 By-health Co., Ltd. Corporation Information
6.5.2 By-health Co., Ltd. Description and Business Overview
6.5.3 By-health Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.5.4 By-health Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.5.5 By-health Co., Ltd. Recent Developments/Updates
6.6 Zhejiang Renzhichu Health Industry Co., Ltd.
6.6.1 Zhejiang Renzhichu Health Industry Co., Ltd. Corporation Information
6.6.2 Zhejiang Renzhichu Health Industry Co., Ltd. Description and Business Overview
6.6.3 Zhejiang Renzhichu Health Industry Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zhejiang Renzhichu Health Industry Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.6.5 Zhejiang Renzhichu Health Industry Co., Ltd. Recent Developments/Updates
6.7 Hanguk Insam Gongsa
6.6.1 Hanguk Insam Gongsa Corporation Information
6.6.2 Hanguk Insam Gongsa Description and Business Overview
6.6.3 Hanguk Insam Gongsa Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hanguk Insam Gongsa Medicinal and Food Homologous Health Product Product Portfolio
6.7.5 Hanguk Insam Gongsa Recent Developments/Updates
6.8 Shandong Gubentang Health Industry Development Group Co., Ltd.
6.8.1 Shandong Gubentang Health Industry Development Group Co., Ltd. Corporation Information
6.8.2 Shandong Gubentang Health Industry Development Group Co., Ltd. Description and Business Overview
6.8.3 Shandong Gubentang Health Industry Development Group Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shandong Gubentang Health Industry Development Group Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.8.5 Shandong Gubentang Health Industry Development Group Co., Ltd. Recent Developments/Updates
6.9 Renhe Pharmacy Co., Ltd.
6.9.1 Renhe Pharmacy Co., Ltd. Corporation Information
6.9.2 Renhe Pharmacy Co., Ltd. Description and Business Overview
6.9.3 Renhe Pharmacy Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Renhe Pharmacy Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.9.5 Renhe Pharmacy Co., Ltd. Recent Developments/Updates
6.10 Ningxia Qilixiang Medlar Co., Ltd.
6.10.1 Ningxia Qilixiang Medlar Co., Ltd. Corporation Information
6.10.2 Ningxia Qilixiang Medlar Co., Ltd. Description and Business Overview
6.10.3 Ningxia Qilixiang Medlar Co., Ltd. Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Ningxia Qilixiang Medlar Co., Ltd. Medicinal and Food Homologous Health Product Product Portfolio
6.10.5 Ningxia Qilixiang Medlar Co., Ltd. Recent Developments/Updates
6.11 Nu Skin Enterprises
6.11.1 Nu Skin Enterprises Corporation Information
6.11.2 Nu Skin Enterprises Medicinal and Food Homologous Health Product Description and Business Overview
6.11.3 Nu Skin Enterprises Medicinal and Food Homologous Health Product Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Nu Skin Enterprises Medicinal and Food Homologous Health Product Product Portfolio
6.11.5 Nu Skin Enterprises Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicinal and Food Homologous Health Product Industry Chain Analysis
7.2 Medicinal and Food Homologous Health Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicinal and Food Homologous Health Product Production Mode & Process
7.4 Medicinal and Food Homologous Health Product Sales and Marketing
7.4.1 Medicinal and Food Homologous Health Product Sales Channels
7.4.2 Medicinal and Food Homologous Health Product Distributors
7.5 Medicinal and Food Homologous Health Product Customers
8 Medicinal and Food Homologous Health Product Market Dynamics
8.1 Medicinal and Food Homologous Health Product Industry Trends
8.2 Medicinal and Food Homologous Health Product Market Drivers
8.3 Medicinal and Food Homologous Health Product Market Challenges
8.4 Medicinal and Food Homologous Health Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’